Capel M, Ciudin A, Mareque M, Rodríguez-Rincón RM, Simón S, Oyagüez I Cost-effectiveness analysis of exenatide versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus PharmacoEconomics – Open 2020; 4, 277–286 MÁS INFORMACIÓN
